Company news

electroCore, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

April 17, 2025

electroCore to Participate at the Planet MicroCap Showcase

April 16, 2025

electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times

April 3, 2025

electroCore to Participate at the Needham Virtual Healthcare Conference

April 1, 2025

electroCore Extends VA Contract for Five Years

March 31, 2025

electroCore Announces Full Year 2024 Financial Results

March 12, 2025

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

March 6, 2025

electroCore to Participate at Upcoming Investor Conferences

March 5, 2025

electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

February 27, 2025

electroCore’s Truvaga™ Now Available on Amazon®

February 19, 2025

electroCore Expands Intellectual Property Portfolio

February 5, 2025

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

December 16, 2024

electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award

November 19, 2024

electroCore Announces Third Quarter 2024 Financial Results

November 12, 2024

electroCore Announces Second Quarter 2024 Financial Results

August 6, 2024

electroCore Announces the Commercial Launch of TAC-STIM™

June 24, 2024

electroCore to Join Russell Microcap® Index

June 10, 2024

electroCore, Inc. Announces Closing of $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

June 5, 2024

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

June 2, 2024

electroCore Announces First Quarter 2024 Financial Results

May 7, 2024

electroCore Announces the Launch of Truvaga Plus® for General Wellness

April 7, 2024

electroCore Announces Fourth Quarter and Full Year 2023 Financial Results

March 12, 2024

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

March 4, 2024

electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology

December 11, 2023

electroCore Announces Third Quarter 2023 Financial Results

November 7, 2023

electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue

October 16, 2023

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

October 10, 2023

electroCore to Announce Third Quarter Financial Results on Wednesday, November 8

October 8, 2023

electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering

August 22, 2023

electroCore Announces Second Quarter 2023 Financial Results

August 8, 2023

electroCore to Announce Second Quarter Financial Results on Wednesday, August 9

July 31, 2023

electroCore, Inc. Announces $8.145 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

July 30, 2023

electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC

July 12, 2023

electroCore Provides Select Second Quarter 2023 Financial Guidance

July 10, 2023

electroCore Announces Poster to be Presented at the American Headache Society’s 65th Annual Scientific Meeting

June 12, 2023

electroCore, Inc. Announces Departure of JP Errico from the Board of Directors

May 25, 2023

electroCore Announces First Quarter 2023 Financial Results

May 2, 2023

electroCore to Announce First Quarter Financial Results on Wednesday, May 3

April 18, 2023

electroCore Provides Select First Quarter 2023 Financial Guidance

April 16, 2023

electroCore Expands Intellectual Patent Portfolio for nVNS Technology

April 11, 2023

electroCore Announces Remittance of Annual License Fee from Teijin for Certain Exclusive Rights in Japan

April 10, 2023

electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South Africa

April 5, 2023

electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through the Carrick Institute

April 3, 2023

electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury

March 22, 2023

electroCore Announces Fourth Quarter and Full Year 2022 Financial Results

March 7, 2023

electroCore Regains Compliance with Nasdaq Listing Requirements

March 6, 2023

electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8

February 28, 2023

electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa

February 20, 2023

electroCore Expands Intellectual Patent Portfolio for nVNS Technology

February 15, 2023

electroCore Completes Sale of New Jersey Tax Benefits

February 14, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 14 decks. Every deck is listed under its year.